KEAP1 and lung adenocarcinoma: KEAP1 mutations, which typically decrease ubiquitylation and turnover of Nrf2, are found in 16.8% (154/915) of recent lung adenocarcinoma samples (MSK-IMPACT) [68], while CUL3 mutations are infrequent at 1.5% (14/915).